2023-03-17 08:18:00 ET
- Indaptus Therapeutics press release ( NASDAQ: INDP ): FY GAAP EPS of -$1.73 beats by $0.21 .
- As of December 31, 2022, the company had cash and cash equivalents and marketable securities of approximately $26.4 million.
- As of December 31, 2021, the company had cash and cash equivalents of approximately $39.1 million.
- The company expects that its current cash, cash equivalents and marketable securities will support its ongoing operating activities into the second quarter of 2024.
For further details see:
Indaptus Therapeutics GAAP EPS of -$1.73 beats by $0.21